IBL HealthCare Limited (PSX:IBLHL)

Market Cap	4.93B
Revenue (ttm)	4.32B
Net Income (ttm)	208.37M
Shares Out	98.53M
EPS (ttm)	2.11
PE Ratio	23.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	134,409
Average Volume	546,867
Open	49.54
Previous Close	49.43
Day's Range	49.01 - 50.20
52-Week Range	24.09 - 61.74
Beta	0.72
RSI	45.52
Earnings Date	Oct 3, 2025

About IBL HealthCare

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddler, baby cereals, infant formulas, medical, lifestyle nutrition, and specialty nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such as ...

• Industry: Food & Drug Retailing
• Sector: Consumer Non-Cyclicals
• Founded: 1997
• Employees: 224
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: IBLHL

Financial Performance

In 2025, IBL HealthCare's revenue was 4.32 billion, an increase of 19.96% compared to the previous year's 3.60 billion. Earnings were 208.37 million, an increase of 2658.05%.